IDEAS home Printed from https://ideas.repec.org/r/wly/hlthec/v11y2002i4p341-353.html
   My bibliography  Save this item

Estimating an EQ‐5D population value set: the case of Japan

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Samer A. Kharroubi & Yara Beyh & Marwa Diab El Harake & Dalia Dawoud & Donna Rowen & John Brazier, 2020. "Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population," IJERPH, MDPI, vol. 17(3), pages 1-15, February.
  2. Bansback, Nick & Brazier, John & Tsuchiya, Aki & Anis, Aslam, 2012. "Using a discrete choice experiment to estimate health state utility values," Journal of Health Economics, Elsevier, vol. 31(1), pages 306-318.
  3. Brazier, J, 2005. "Current state of the art in preference-based measures of health and avenues for further research," MPRA Paper 29762, University Library of Munich, Germany.
  4. Rodríguez-Míguez, E. & Abellán-Perpiñán, J.M. & Alvarez, X.C. & González, X.M. & Sampayo, A.R., 2016. "The DEP-6D, a new preference-based measure to assess health states of dependency," Social Science & Medicine, Elsevier, vol. 153(C), pages 210-219.
  5. Feng Xie & A. Pickard & Paul Krabbe & Dennis Revicki & Rosalie Viney & Nancy Devlin & David Feeny, 2015. "A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)," PharmacoEconomics, Springer, vol. 33(8), pages 867-877, August.
  6. Ryan G Wagner & Fredrick Ibinda & Stephen Tollman & Lars Lindholm & Charles R Newton & Melanie Y Bertram, 2015. "Differing Methods and Definitions Influence DALY estimates: Using Population-Based Data to Calculate the Burden of Convulsive Epilepsy in Rural South Africa," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-12, December.
  7. Kelvin K. W. Chan & Feng Xie & Andrew R. Willan & Eleanor M. Pullenayegum, 2018. "Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size," Medical Decision Making, , vol. 38(1), pages 26-33, January.
  8. Imai, Hirohisa & Fujii, Yoshinori & Fukuda, Yoshiharu & Nakao, Hiroyuki & Yahata, Yuichiro, 2008. "Health-related quality of life and beneficiaries of long-term care insurance in Japan," Health Policy, Elsevier, vol. 85(3), pages 349-355, March.
  9. L. M. Lamers & J. McDonnell & P. F. M. Stalmeier & P. F. M. Krabbe & J. J. V. Busschbach, 2006. "The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1121-1132, October.
  10. Garry R. Barton & Tracey H. Sach & Anthony J. Avery & Claire Jenkinson & Michael Doherty & David K. Whynes & Kenneth R. Muir, 2008. "A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years," Health Economics, John Wiley & Sons, Ltd., vol. 17(7), pages 815-832, July.
  11. Eleanor Pullenayegum & Kuhan Perampaladas & Kathryn Gaebel & Brett Doble & Feng Xie, 2015. "Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 847-855, November.
  12. Samer Kharroubi, 2015. "A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 409-420, August.
  13. Méndez, Ildefonso & Abellán Perpiñán, Jose M. & Sánchez Martínez, Fernando I. & Martínez Pérez, Jorge E., 2011. "Inverse probability weighted estimation of social tariffs: An illustration using the SF-6D value sets," Journal of Health Economics, Elsevier, vol. 30(6), pages 1280-1292.
  14. Nan Luo & Pei Wang & Julian Thumboo & Yee-Wei Lim & Hubertus Vrijhoef, 2014. "Valuation of EQ-5D-3L Health States in Singapore: Modeling of Time Trade-Off Values for 80 Empirically Observed Health States," PharmacoEconomics, Springer, vol. 32(5), pages 495-507, May.
  15. Mathieu F. Janssen & Gouke J. Bonsel & Nan Luo, 2018. "Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries," PharmacoEconomics, Springer, vol. 36(6), pages 675-697, June.
  16. Michał Jakubczyk, 2009. "Impact of Complementarity and Heterogeneity on Health Related Utility of Life," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 1(2), pages 139-156, November.
  17. Mônica Viegas Andrade & Kenya Noronha & Paul Kind & Carla de Barros Reis & Lucas Resende de Carvalho, 2016. "Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States," Medical Decision Making, , vol. 36(2), pages 242-252, February.
  18. Munir A. Khan & Jeff Richardson, 2019. "Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 145(1), pages 1-15, August.
  19. John Brazier & Jennifer Roberts & Aki Tsuchiya & Jan Busschbach, 2004. "A comparison of the EQ‐5D and SF‐6D across seven patient groups," Health Economics, John Wiley & Sons, Ltd., vol. 13(9), pages 873-884, September.
  20. P. Wang & M. Li & G. Liu & J. Thumboo & N. Luo, 2015. "Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(8), pages 857-863, November.
  21. Leida M. Lamers & Peep F. M. Stalmeier & Paul F. M. Krabbe & Jan J. V. Busschbach, 2006. "Inconsistencies in TTO and VAS Values for EQ-5D Health States," Medical Decision Making, , vol. 26(2), pages 173-181, March.
  22. Yaling Yang & John Brazier & Aki Tsuchiya, 2014. "Effect of Adding a Sleep Dimension to the EQ-5D Descriptive System," Medical Decision Making, , vol. 34(1), pages 42-53, January.
  23. Jose María Abellán Perpiñán & Fernando Ignacio Sánchez Martínez & Jorge Eduardo Martínez Pérez & Ildefonso Méndez Martínez, 2009. "Debiasing EQ-5D Tariffs. New estimations of the spanish EQ-5D value set under nonexpected utility," Economic Working Papers at Centro de Estudios Andaluces E2009/06, Centro de Estudios Andaluces.
  24. Mimmi Åström & Ola Rolfson & Kristina Burström, 2022. "Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents," Applied Health Economics and Health Policy, Springer, vol. 20(3), pages 383-393, May.
  25. Chun Fan Lee & Raymond Ng & Nan Luo & Yin Bun Cheung, 2018. "Development of Conversion Functions Mapping the FACT-B Total Score to the EQ-5D-5L Utility Value by Three Linking Methods and Comparison with the Ordinary Least Square Method," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 685-695, October.
  26. Hidetoshi Shibahara & Takeru Shiroiwa & Megumi Ishiguro & Masato Nakamura & Junichi Hasegawa & Shigeki Yamaguchi & Yuriko Masuda & Junichi Sakamoto & Naohiro Tomita & Takashi Fukuda, 2022. "Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(7), pages 1159-1171, September.
  27. Yasuhiro Hagiwara & Takeru Shiroiwa & Kojiro Shimozuma & Takuya Kawahara & Yukari Uemura & Takanori Watanabe & Naruto Taira & Takashi Fukuda & Yasuo Ohashi & Hirofumi Mukai, 2018. "Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study," PharmacoEconomics, Springer, vol. 36(2), pages 215-223, February.
  28. Shan Lu & Yupan Wu & Zongfu Mao & Xiaohui Liang, 2020. "Association of Formal and Informal Social Support With Health-Related Quality of Life Among Chinese Rural Elders," IJERPH, MDPI, vol. 17(4), pages 1-14, February.
  29. Irina Cleemput, 2010. "A social preference valuations set for EQ-5D health states in Flanders, Belgium," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 205-213, April.
  30. Julie Chevalier & Gérard Pouvourville, 2013. "Valuing EQ-5D using Time Trade-Off in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 57-66, February.
  31. Richard Norman & Paula Cronin & Rosalie Viney, 2012. "Deriving utility weights for the EQ-5D-5L using a discrete choice experiment. CHERE Working Paper 2012/01," Working Papers 2012/01, CHERE, University of Technology, Sydney.
  32. Mathieu F. Janssen & Ines Buchholz & Dominik Golicki & Gouke J. Bonsel, 2022. "Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries," PharmacoEconomics, Springer, vol. 40(11), pages 1081-1093, November.
  33. Chunmei Wu & Yanhong Gong & Jiang Wu & Shengchao Zhang & Xiaoxv Yin & Xiaoxin Dong & Wenzhen Li & Shiyi Cao & Naomie Mkandawire & Zuxun Lu, 2016. "Chinese Version of the EQ-5D Preference Weights: Applicability in a Chinese General Population," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.
  34. Kelvin K. W. Chan & Eleanor M. Pullenayegum, 2020. "The Theoretical Relationship between Sample Size and Expected Predictive Precision for EQ-5D Valuation Studies: A Mathematical Exploration and Simulation Study," Medical Decision Making, , vol. 40(3), pages 339-347, April.
  35. W. Greiner & C. Claes & J. J. V. Busschbach & J.-M. Schulenburg, 2005. "Validating the EQ-5D with time trade off for the German population," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 124-130, June.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.